BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34890645)

  • 21. Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver.
    Hoeger B; Diether M; Ballester PJ; Köhn M
    Eur J Med Chem; 2014 Dec; 88():89-100. PubMed ID: 25159123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphatase of regenerating liver-1 promotes cell migration and invasion and regulates filamentous actin dynamics.
    Nakashima M; Lazo JS
    J Pharmacol Exp Ther; 2010 Aug; 334(2):627-33. PubMed ID: 20484558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRL-3 phosphatase and cancer metastasis.
    Al-Aidaroos AQ; Zeng Q
    J Cell Biochem; 2010 Dec; 111(5):1087-98. PubMed ID: 21053359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
    McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
    Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphatase of Regenerating Liver-1 (PRL-1) Regulates Actin Dynamics During Immunological Synapse Assembly and T Cell Effector Function.
    Castro-Sánchez P; Ramirez-Munoz R; Martín-Cófreces NB; Aguilar-Sopeña O; Alegre-Gomez S; Hernández-Pérez S; Reyes R; Zeng Q; Cabañas C; Sánchez-Madrid F; Roda-Navarro P
    Front Immunol; 2018; 9():2655. PubMed ID: 30515156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of thienopyridone and iminothienopyridinedione inhibition of protein phosphatases.
    Zhang Z; Kozlov G; Chen YS; Gehring K
    Medchemcomm; 2019 May; 10(5):791-799. PubMed ID: 31191869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphatase of Regenerating Liver-1 Regulates Wing Vein Formation through TGF-β Pathway in
    Zheng H; Lou Z; Yuan X; Wu H; Yang X; Xi Y
    Front Biosci (Landmark Ed); 2022 Jun; 27(6):176. PubMed ID: 35748252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
    Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
    Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the protein tyrosine phosphatase PRL from Entamoeba histolytica.
    Ramírez-Tapia AL; Baylón-Pacheco L; Espíritu-Gordillo P; Rosales-Encina JL
    Exp Parasitol; 2015 Dec; 159():168-82. PubMed ID: 26431820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Roles of Pseudophosphatases in Disease.
    Mattei AM; Smailys JD; Hepworth EMW; Hinton SD
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emerging roles and therapeutic potential of cyclin M/CorC family of Mg
    Funato Y; Miki H
    J Pharmacol Sci; 2022 Jan; 148(1):14-18. PubMed ID: 34924118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer.
    Hwang JJ; Min SH; Sin KH; Heo YS; Kim KD; Yoo OJ; Lee SH
    Oncol Rep; 2012 Feb; 27(2):535-40. PubMed ID: 21993571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and Evaluation of PRL Trimer Disruptors for Novel Anticancer Agents.
    Bai Y; Yu ZH; Zhang ZY
    Methods Mol Biol; 2016; 1447():121-38. PubMed ID: 27514804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion.
    Sun JP; Wang WQ; Yang H; Liu S; Liang F; Fedorov AA; Almo SC; Zhang ZY
    Biochemistry; 2005 Sep; 44(36):12009-21. PubMed ID: 16142898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatase activity, trimerization, and the C-terminal polybasic region are all required for PRL1-mediated cell growth and migration.
    Sun JP; Luo Y; Yu X; Wang WQ; Zhou B; Liang F; Zhang ZY
    J Biol Chem; 2007 Sep; 282(39):29043-29051. PubMed ID: 17656357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localizing PRL-2 expression and determining the effects of dietary Mg(2+) on expression levels.
    Gungabeesoon J; Tremblay ML; Uetani N
    Histochem Cell Biol; 2016 Jul; 146(1):99-111. PubMed ID: 27015884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procyanidins Negatively Affect the Activity of the Phosphatases of Regenerating Liver.
    Stadlbauer S; Rios P; Ohmori K; Suzuki K; Köhn M
    PLoS One; 2015; 10(7):e0134336. PubMed ID: 26226290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatase of regenerating liver in hematopoietic stem cells and hematological malignancies.
    Kobayashi M; Chen S; Gao R; Bai Y; Zhang ZY; Liu Y
    Cell Cycle; 2014; 13(18):2827-35. PubMed ID: 25486470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer.
    Gao PP; Qi XW; Sun N; Sun YY; Zhang Y; Tan XN; Ding J; Han F; Zhang Y
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188562. PubMed ID: 33964330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.